BioHealth News Archive

Join CEO Tami Howie for a fireside chat with Lyft – TEDCO’s Entrepreneur Expo & Stem Cell Symposium 2017

Join CEO Tami Howie for a fireside chat with Lyft – TEDCO’s Entrepreneur Expo & Stem Cell Symposium 2017

Join Maryland Tech Council CEO, Tami Howie, at the 7th Annual TEDCO's Entrepreneur Expo on October 25, 2017 for a fireside chat with Mike…

Read More
It’s official: AstraZeneca and MedImmune ranked a top place for scientists to work by Science

It’s official: AstraZeneca and MedImmune ranked a top place for scientists to work by Science

AstraZeneca and MedImmune, our global biologics research and development arm, have been voted one of the top science employers worldwide, in the prestigious Science…

Read More
Innovative pharma contracts: When do value-based arrangements work? – McKinsey & Company

Innovative pharma contracts: When do value-based arrangements work? – McKinsey & Company

Many are exploring alternatives to traditional ‘per pill’ arrangements underlying reimbursement. This holds implications for pharma manufacturers. {iframe}https://www.mckinsey.com/industries/pharmaceuticals-and-medical-products/our-insights/innovative-pharma-contracts-when-do-value-based-arrangements-work?cid=other-eml-alt-mip-mck-oth-1710{/iframe}

Read More
Science in the City – UM BioPark –  OCTOBER 26, 2017

Science in the City – UM BioPark – OCTOBER 26, 2017

OCTOBER 26, 2017 Host:  UM BioPark & Wexford Science + Technology Location:  UM BioPark Life Sciences Conference Centeer 801 W. Baltimore Street Baltimore  Maryland  21201 Time: …

Read More
Black & White Affair

Black & White Affair

Thursday, December 07, 2017 5:30 PM - 7:30 PM EST Horseshoe Casino Baltimore 1525 Russell Street Baltimore, MD 21230 We're excited to announce MTC's…

Read More
Ruppersberger Calls BioPark ‘Formula That Works’ – University of Maryland, Baltimore

Ruppersberger Calls BioPark ‘Formula That Works’ – University of Maryland, Baltimore

Since the launch of the BioPark Initiative in 2003, the BioPark has grown to include nearly three dozen companies with more than 1,000 employees.…

Read More
F.D.A. Approves Second Gene-Altering Treatment for Cancer – The New York Times

F.D.A. Approves Second Gene-Altering Treatment for Cancer – The New York Times

The Food and Drug Administration on Wednesday approved the second in a radically new class of treatments that genetically reboot a patient’s own immune…

Read More
Inova Health System names Rick Gordon its new director of its personalized medicine accelerator – Washington Business Journal

Inova Health System names Rick Gordon its new director of its personalized medicine accelerator – Washington Business Journal

Inova Health System is bringing Northern Virginia tech investor Rick Gordon into the fold. {iframe}https://www.bizjournals.com/washington/news/2017/10/18/former-mach37-partner-joins-inovas-personalized.html?ana=e_ae_set3&s=article_du&ed=2017-10-18&u=wjGEy67ABoSnsLErlc5ry0j5hx3&t=1508418739&j=79016211{/iframe}

Read More
Superstar Effect: Venture Capital Investments – Newgeography.com

Superstar Effect: Venture Capital Investments – Newgeography.com

This is the latest in my “superstar effect” series. Richard Florida posted an interesting analysis of venture capital investments over at City Lab. {iframe}http://www.newgeography.com/content/005770-superstar-effect-venture-capital-investments?utm_source=feedburner&utm_medium=email&utm_campaign=Feed%3A+Newgeography+%28Newgeography.com+-+Economic%2C+demographic%2C+and+political+commentary+about+places%29{/iframe}

Read More
Biotech builder Cydan gets cash injection for genetic disorders – FierceBiotech

Biotech builder Cydan gets cash injection for genetic disorders – FierceBiotech

Drug accelerator Cydan has gained a $34 million injection as it eyes deeper inroads into rare diseases for its second fund. {iframe}http://www.fiercebiotech.com/biotech/drug-accelerator-cydan-gets-cash-injection-for-genetic-disorders{/iframe}

Read More
Intrexon inks $100M funding deal with billionaire founder Randal Kirk – Washington Business Journal

Intrexon inks $100M funding deal with billionaire founder Randal Kirk – Washington Business Journal

Germantown-based bioengineering company Intrexon Corp. will have access to up to $100 million of new capital through a deal with an affiliate company controlled…

Read More
1313 Innovation’s co-working partner combines with Washington, DC’s 1776 – Delaware Business Now

1313 Innovation’s co-working partner combines with Washington, DC’s 1776 – Delaware Business Now

The operating partner for 1313 Innovation’s co-working space in Wilmington is merging with a Washington, DC organization. 1313 operates from the Hercules Plaza building…

Read More
Illumina Ventures Closes First Venture Capital Fund, at $230M

Illumina Ventures Closes First Venture Capital Fund, at $230M

Illumina Ventures, a San Francisco-based early-stage venture capital firm, closed its maiden fund, at $230m. Launched with an initial $100m investment from Illumina, Illumina…

Read More
VLP Therapeutics Announces Phase 1 SBIR Grant Award From National Cancer Institute – VLP Therapeutics

VLP Therapeutics Announces Phase 1 SBIR Grant Award From National Cancer Institute – VLP Therapeutics

VLP Therapeutics, LLC (“VLP”), a biotechnology company focusing on the research and development of therapeutic and preventative vaccines announced today the receipt of a…

Read More
New Digital Marketing and IT Specialist Joins the BHI Team

New Digital Marketing and IT Specialist Joins the BHI Team

Brian Smith joined BHI in October of 2017 as a digital marketing and IT specialist. Brian manages BHI’s information technology assets in addition to…

Read More